Skip to content
Buy This GLP
← Research
Evidence

Weight Regain After Stopping Tirzepatide, Semaglutide or Liraglutide

A 17-study review estimated weight regain after stopping treatment. The pooled figures cover different study populations and follow-up periods.

Editorial profile: Carla MedinaBuy This GLP Editorial Team4 min read
Weight regained after stopping, pooledliraglutide 3.0 mg4.83%semaglutide 2.4 mg7.19%tirzepatide13.04%Separate study groups with different follow-up.

A review pooled weight measurements from the end of obesity treatment to a later follow-up [1]. Individual trials in our guide to weight regain after stopping a GLP-1 provide a clearer view of specific follow-up periods. The studies in this pooled analysis differed considerably.

What the pooled figures mean

The review included 17 studies and 3,793 participants in groups that stopped treatment. The pooled estimate of weight regain was 7.20%, with a 95% confidence interval of 5.93% to 8.48% [1]. The percentage describes the change in weight after treatment ended. It does not describe the share of previously lost weight that returned.

Separate estimates were 4.83% for liraglutide, 7.19% for semaglutide and 13.04% for tirzepatide. The groups differed in starting weight, earlier weight loss and time since treatment stopped. Eleven studies were retrospective and only three were randomized. The drug-specific figures are indirect comparisons.

What a randomized withdrawal trial can show

SURMOUNT-4 randomized adults who completed an initial tirzepatide treatment period to continue or switch to placebo [2]. Research on whether a lower dose can maintain weight loss studies a different decision from stopping. Over the next 52 weeks, the placebo group gained 14.0% from its week 36 weight. The group that continued tirzepatide lost another 5.5%. Those figures apply to adults who reached the randomized phase.

Frequently asked

How much weight came back on average?
The pooled estimate was 7.20% of body weight after treatment stopped, with a 95% confidence interval of 5.93% to 8.48%.
Does tirzepatide cause more weight regain?
The pooled tirzepatide estimate was numerically higher. Separate study groups and follow-up periods prevent a reliable direct comparison.
What did a randomized withdrawal trial show?
Participants switched from tirzepatide to placebo gained 14.0% over the next year on average. Those continuing tirzepatide lost another 5.5%.

Sources

  1. [1] Patel H, Babli SA, Shah S, et al. (2026). Post-cessation Weight Regain After Weight Management Medications: A Systematic Review and Meta-Analysis Cureus. PMID 42534203
  2. [2] Aronne LJ, Sattar N, Horn DB, et al. (2024). Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial JAMA. PMID 38078870

Where to get it

The cheapest GLP-1

Every seller that publishes a price, ordered lowest first on the standing month-to-month rate, plus the question to ask before you pay any of them.

See the board →

More in Evidence